Nuclear Oncology Institute is a scientific organization that brings together the resources of academic centers,  hospitals, clinics, imaging and treatment centers, research laboratories and industry entities invested in the fields of nuclear medicine and oncology. The objective of the Nuclear Oncology Institute is to foster  scientific creativity and productivity towards development of  novel and effective techniques for cancer diagnosis and therapy.

A panel of expert scientists including  five Florida International University faculty  and  two scientific advisory committee members guide all of CRI’s research and development decisions. Only the most compelling and competitive research projects are selected to receive NOI support.

Through its paralleled clinical investigation programs such as the liver cancer imaging and therapy, and Neuroendocrine Tumor /  thyroid cancer imaging and therapy programs and the Coordinated Cancer Initiatives, NOI convenes and directs international teams of scientists and clinicians who work together more efficiently toward shared goals.

Nuclear Oncology Institute’s funding comes from  donations, earned federal grants and industry support. The funding grant to the institution was provided by Rinker Family Foundation. NOI’s donors can be certain their gifts will make the most impact.

Steering Committee

Seza A Gulec, MD, FACS

Anthony McGoron, PhD

J Patrick O’Leary, MD, FACS

Gregory Hiat, RPh

Stanley Satz, PhD

Alejandro Amor, MS

Malek Adjuadi, PhD

David Graham, MD, MBA

Manuel Viamonte, MD

Aaron Berkman, MD

Michael Karl, MD

Kenneth Pennington, MD

Yuman Fong, MD, FACS